Persistent inhibition of gastric secretion by an intravenous 12-hour infusion of calcitonin in normals, peptic ulcer and high risk patients.
D000293:Adolescent; D000328:Adult; D002116:Calcitonin / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use; D003864:Depression, Chemical; D005260:Female; D005745:Gastric Acidity Determination; D005750:Gastric Juice / Q000378:metabolism*; D006261:Headache / Q000139:chemically induced; D006801:Humans; D008297:Male; D008875:Middle Aged; D009325:Nausea / Q000139:chemically induced; D010434:Pepsin A / Q000378:metabolism; D010437:Peptic Ulcer / Q000188:drug therapy* / Q000378:metabolism; D012636:Secretory Rate / Q000187:drug effects
D002116:Calcitonin; D010434:Pepsin A